3032
T. Q. Faria et al. / Carbohydrate Research 343 (2008) 3025–3033
170.7, 169.8, 169.7, 169.6, 135.5, 135.4, 133.1, 133.0, 132.9, 129.8,
129.7, 127.8, 127.8, 127.7, 96.6, 77.7, 69.5, 69.3, 68.2, 65.9, 63.8,
63.1, 62.2, 26.8, 26.7, 20.8, 20.7, 20.6, 19.1. FT-IR 1752.6 cmꢁ1
(C@O).
(7.5 mL) at 0 °C. After 30 min, saturated aqueous NH4Cl (15 mL)
was added. The aqueous phase was extracted with AcOEt
(3 ꢃ 20 mL), and the combined organic extracts were dried
(MgSO4), filtered and the solvent removed. Purification by medium
pressure column chromatography (10:90 to 20:80 AcOEt/hexane)
afforded the product 11 as very colourless viscous foam (1.79 g,
4.2.6. 1-O-(2-Glyceryl)-a-D-mannopyranoside 8
To a solution of 7 (35 g, 0.039 mol) in THF (120 mL) was added
TBAF (25 g, 0.098 mol) at rt. After all the starting material had been
consumed, H2O (60 mL) was added. The aqueous phase was ex-
tracted with AcOEt (3 ꢃ 80 mL), the combined organic phases were
dried (MgSO4) and then concentrated. The obtained residue was
used in the next reaction without further purification. In order to
characterize this compound, only a small sample was purified by
preparative TLC (50:50 AcOEt/hexane), and 2,3,4,6-tetra-O-acetyl-
94%). ½a 2D0
ꢄ
+17.2 (c 1.49, CH2Cl2). 1H NMR (CDCl3): d 7.70–7.67
(5H, m), 7.44–7.24 (25H, m), 5.14 (1H, d, J = 3.5 Hz), 4.99 (1H, d,
J = 10.8 Hz), 4.90 (1H, d, J = 11.5 Hz), 4.88 (1H, d, J = 11.2 Hz), 4.78
(1H, d, J = 10.1 Hz), 4.71 (1H, d, J = 11.7 Hz), 4.62 (1H, d,
J = 11.3 Hz), 4.46 (1H, dd, J = 6.1 Hz, J = 4.3 Hz), 4.13–3.95 (3H, m),
3.35–3.79 (1H, m), 3.74 (3H, s), 3.70–3.45 (5H, m), 1.03 (9H, s).
13C NMR (CDCl3): d 170.3, 138.8, 138.4, 138.2, 135.6, 135.5,
133.0, 132.8, 129.7, 128.3, 128.1, 128.0, 127.7, 127.6, 127.5, 94.9,
81.5, 79.3, 76.9, 75.7, 74.8, 74.7, 72.1, 71.2, 64.6, 61.6, 51.9, 26.7,
19.1. FT-IR 1752.8 cmꢁ1 (C@O). HR-MS: Calcd for C47H54O9Si
[M]+: 790.3531; found: 790.3500.
1-O-(2-glyceryl)-a-D-mannopyranoside (96%) was isolated as a
colourless viscous foam. ½a D20
ꢄ
+33.8 (c 0.66, CH2Cl2). 1H NMR
(CDCl3): d 5.35 (1H, dd, J = 10.0 Hz, J = 3.3 Hz), 5.31–5.26 (2H, m),
5.05 (1H, d, J = 1.6 Hz), 4.25–4.15 (3H, m), 3.82–3.73 (5H, m) 2.16
(3H, s), 2.11 (3H, s), 2.06 (3H, s), 2.01 (3H, s). 13C NMR (CDCl3): d
170.7, 170.2, 170.1, 169.7, 96.5, 81.2, 69.7, 69.0, 66.2, 63.0, 62.7,
62.1, 20.8, 20.7. FT-IR 1745.6 cmꢁ1 (C@O). To a solution of the pre-
vious compound (16 g, 0.038 mol) in MeOH (50 mL) was added
MeONa (1 N in MeOH, 24.7 mL) at rt. After 3 h, all the starting
material had been consumed. The solution was diluted with MeOH,
and Dowex 50 WX8 resin was added until pH 6. Filtration and
evaporation of the solvents afforded a viscous residue, which was
diluted with water (20 mL) and washed with CH2Cl2 twice
(2 ꢃ 10 mL). The aqueous phase was concentrated and furnished
8 (9.6 g, 90%) as a colourless viscous foam, which was purified as
4.2.9. (2R)-2-(a-D-Glucopyranosyl)glycerate, potassium salt 12
To a solution of 11 (3.00 g, 3.8 mmol) in THF (15 mL) at rt was
added Bu4NF (1.20 g, 4.6 mmol). The reaction mixture was stirred
for 3 h and then water was added. The mixture was extracted with
AcOEt (3 ꢃ 20 mL), dried (MgSO4) and concentrated to furnish a
yellow viscous residue. Purification by medium pressure column
chromatography (50:50 to 100% AcOEt) afforded the product
methyl
(2R)-2-(2,3,4-tri-O-benzyl-a-D-glucopyranosyl)glycerate
as a very colourless viscous foam (1.89 g, 90%). ½a D20
ꢄ
+49.5 (c
1.16, CH2Cl2). 1H NMR (CDCl3): d 7.43–7.26 (18H, m), 5.20 (1H, d,
J = 3.6 Hz), 5.00 (1H, d, J = 10.8 Hz), 4.92–4.80 (3H, m), 4.70 (1H,
d, J = 11.4 Hz), 4.62 (1H, d, J = 10.8 Hz), 4.36 (1H, t, J = 4.3 Hz),
4.03 (1H, t, J = 9.3 Hz), 3.93 (2H, d, J = 4.5 Hz), 3.76 (3H, s), 3.75–
3.52 (4H, m), 2.09 (2H, br s). 13C NMR (CDCl3): d 170.1, 138.6,
137.9, 137.7, 128.5, 128.4, 128.3, 127.9, 94.9, 81.3, 79.4, 77.1,
75.7, 75.1, 74.6, 72.4, 71.6, 63.3, 61.7, 52.1. HR-MS: Calcd for
C31H36O9 [M]+: 552.2354; found: 552.2333. Methyl (2R)-2-(2,3,4-
described above. ½a D20
ꢄ
+30.3 (c 1.5, H2O). 1H NMR (D2O): d 4.89
(1H, d, J = 1.6 Hz), 3.84 (1H, q, J = 1.8 Hz), 3.74–3.48 (10H, m). 13C
NMR (D2O): d 99.3, 78.0, 72.9, 70.4, 70.2, 66.7, 61.3, 60.9, 60.1.
FT-IR 3413 cmꢁ1 (O–H).
4.2.7. Methyl 3-tert-butyldiphenylsilyl-(2R)-2-(6-O-acetyl-2,3,4-
tri-O-benzyl-
a
-D
-glucopyranosyl)glycerate 10
tri-O-benzyl-a-D-glucopyranosyl)glycerate (1.89 g, 3.4 mmol) in
To a stirred solution containing the thioglycoside 922 (2.86 g,
5.3 mmol), 1-benzenesulfinyl piperidine (BSP, 1.12 g, 5.3 mmol),
2,6-di-tert-butyl-4-methylpyridine (DTBMP, 2.14 g, 10.6 mmol)
and powdered 4 Å sieves in CH2Cl2 (25 mL) at ꢁ78 °C was added
Tf2O (1.00 mL, 5.8 mmol). After 5 min, a solution of methyl (2R)-
3-tert-butyldiphenylsilylglycerate (2.86 g, 7.9 mmol) in CH2Cl2
(10 mL) was added. The reaction mixture was stirred 10 min at
ꢁ78 °C and 10 min at 0 °C and quenched with saturated aqueous
NaHCO3 (40 mL). The aqueous phase was extracted with CH2Cl2
(3 ꢃ 25 mL), the combined organic phases were dried (MgSO4), fil-
tered and the solvent removed under vacuum. Purification by med-
ium pressure column chromatography (5:95 to 10:90 AcOEt/
hexane) afforded the product 10 as colourless viscous foam
AcOEt/EtOH (20 mL/10 mL) was hydrogenated at 35 psi in the
presence of a catalytic amount of Pd/C 10% (0.05 equiv). After
3 h, the reaction mixture was filtrated, the solvent was evaporated
and the residue dried under vacuum to afford methyl (2R)-2-(a-D-
glucopyranosyl)glycerate as very colourless viscous foam (0.95 g,
99%). No further purification was needed and we proceeded to
the next step. To a solution of methyl (2R)-2-(a-D-glucopyranos-
yl)glycerate (0.95 g, 3.4 mmol) in H2O (10 mL) was added a 2 M
KOH aqueous solution (1.65 mL). The reaction was stirred over-
night at rt. The pH was neutralized with HCl 10% and the solvent
evaporated to afford 12 as a very colourless viscous foam in the
form of its potassium salt. Its NMR data were identical to those
of the natural sample. ½a D20
ꢄ
+97.6 (c 2.08, H2O). 1H NMR (D2O): d
(4.44 g, 76%).
½
a 2D0
ꢄ
+45.2 (c 1.45, CH2Cl2). FT-IR (film)
5.00 (1H, d, J = 3.7 Hz), 4.39 (1H, t, J = 3.5 Hz), 3.89–3.87 (2H, m),
3.78–3.62 (4H, m), 3.49 (1H, dd, J = 9.8 Hz, J = 3.9 Hz), 3.34 (1H, t,
J = 9.1 Hz). 13C NMR (D2O): d 176.2 (C@O), 100.1 (C-1), 78.1, 75.3,
75.0, 73.9, 72.0, 65.1, 63.0. FT-IR
1744.3 cmꢁ1 (C@O). 1H NMR (CDCl3): d 7.38–7.37 (5H, m), 7.37–
7.22 (25H, m), 5.16 (1H, d, J = 3.3 Hz), 5.02 (1H, d, J = 10.6 Hz),
4.89 (2H, dd, J = 11.9 Hz, J = 3.1 Hz), 4.76 (1H, d, J = 10.5 Hz), 4.70
(1H, d, J = 11.8 Hz), 4.54 (1H, d, J = 11.2 Hz), 4.49 (1H, dd,
J = 6.3 Hz; J = 4.3 Hz), 4.15–3.94 (6H, m), 3.73 (3H, s), 3.60 (1H,
dd, J = 9.7 Hz, J = 3.5 Hz), 3.48 (1H, t, J = 9.5 Hz), 1.99 (3H, s), 1.03
(9H, s). 13C NMR (CDCl3): d 170.6, 170.2, 138.7, 138.1, 138.0,
135.6, 135.5, 133.0, 132.8, 129.8, 129.8, 128.4, 128.3, 128.2,
128.2, 128.1, 127.8, 127.7, 127.6, 94.8, 81.6, 75.8, 74.8, 72.0, 71.9,
69.0, 65.8, 64.6, 62.9, 51.9, 26.7, 20.8, 19.1. HR-MS: Calcd for
C49H56O10Si [M]+: 559.2130; found: 559.2125.
4.3. Differential scanning calorimetry
Differential scanning calorimetry (DSC) was performed on a
MicroCal VP-DSC MicroCalorimeter controlled by the VP-viewer
program and equipped with 0.51 mL cells. Calibration of tempera-
ture and heat-flow was carried out according to MicroCal instruc-
tions. Protein stock solutions of nuclease or MDH were prepared in
phosphate buffer (10 mM of sodium phosphate, pH 7.5), and lyso-
zyme was prepared in citrate buffer (20 mM sodium citrate,
55 mM NaCl, pH 6.0). These stock solutions were extensively dia-
lyzed against the same buffer before the assays. A volume of
2 mL of buffer with or without solutes was prepared and dispensed
4.2.8. Methyl 3-tert-butyldiphenylsilyl-(2R)-2-(2,3,4-tri-O-
benzyl-a-D-glucopyranosyl)glycerate 11
A solution (7.6 mL) of Na (0.046 g) in MeOH (10 mL) was added
to a stirred solution of the acetate 10 (2.0 g, 2.4 mmol) in MeOH